Plain-English translation of NCT06217185 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether , when combined with two other medications ( and ), can help treat advanced breast cancer that has come back after previous treatment. The study will follow about 100 women to see how well this three-drug combination works and what side effects occur.
Some women's breast cancers return even after being treated with one of these medications already. Researchers want to know if combining this medication with two other drugs might work better for women in this situation.
You would receive the three-drug combination treatment for 6–8 cycles (each cycle typically lasts about 3 weeks). After that, if you cannot tolerate the treatment or complete the cycles, you would switch to a different oral medication combined with the other two drugs. Throughout the trial, your doctors would monitor how well the treatment is working and watch for side effects through regular visits and imaging scans.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China